La médecine personnalisée; entre thérapie ciblée et thérapie génique
| dc.contributor.advisor | Gaouazi, A. | |
| dc.contributor.author | Samine Soufiane | |
| dc.date.accessioned | 2023-09-15T13:41:21Z | |
| dc.date.accessioned | 2026-01-22T13:33:16Z | |
| dc.date.available | 2023-09-15T13:41:21Z | |
| dc.date.issued | 2018 | |
| dc.description.collaborator | Ibrahimi | |
| dc.description.collaborator | A. | |
| dc.description.collaborator | Ouadghiri | |
| dc.description.collaborator | M. | |
| dc.description.collaborator | El Hafidi | |
| dc.description.collaborator | N. | |
| dc.identifier.uri | https://toubkal.imist.ma/handle/123456789/19021 | |
| dc.identifier.uri | https://doi.org/10.83129/toubkal-10062 | |
| dc.language.iso | fr | |
| dc.publisher | Université Mohammed 5 de Rabat, Faculté de Médecine et de Pharmacie, Rabat | fr_FR |
| dc.subject | Médecine personnalisée | fr_FR |
| dc.subject | Thérapie ciblée | fr_FR |
| dc.subject | Inhibiteur de la tyrosine kinase | fr_FR |
| dc.subject | Anticorps monoclonaux | fr_FR |
| dc.subject | Thérapie génique | fr_FR |
| dc.subject | CRISPR - Cas 9 | fr_FR |
| dc.subject.other | Sciences médicales | |
| dc.subject.specific | Pharmacie clinique | |
| dc.title | La médecine personnalisée; entre thérapie ciblée et thérapie génique | fr_FR |
Files
Original bundle
1 - 1 of 1